D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 65 Citations 12,712 133 World Ranking 1567 National Ranking 686

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Bacteria

His primary areas of investigation include Biochemistry, Bactericidal/permeability-increasing protein, Escherichia coli, Microbiology and Bacteria. His study brings together the fields of Molecular biology and Biochemistry. His Bactericidal/permeability-increasing protein research is multidisciplinary, incorporating perspectives in Lipopolysaccharide, Cytotoxic T cell, Membrane and Active protein.

The study incorporates disciplines such as Neutrophil elastase and Gram-negative bacteria in addition to Microbiology. His Bacteria study integrates concerns from other disciplines, such as Extracellular, Amino acid sequence analysis, Human neutrophil and Host defence. His work deals with themes such as Proinflammatory cytokine, Cell culture and TLR4, which intersect with Cell activation.

His most cited work include:

  • Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. (402 citations)
  • Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations (316 citations)
  • The TLR4 antagonist Eritoran protects mice from lethal influenza infection (289 citations)

What are the main themes of his work throughout his whole career to date?

Jerrold Weiss mainly investigates Biochemistry, Microbiology, Escherichia coli, Bacteria and Bactericidal/permeability-increasing protein. His research in Phospholipase A2, Cell activation, Phospholipase, Enzyme and Receptor are components of Biochemistry. His Microbiology study combines topics from a wide range of disciplines, such as Extracellular, Lipopolysaccharide, Gram-negative bacteria and Staphylococcus aureus.

Jerrold Weiss usually deals with Escherichia coli and limits it to topics linked to Membrane protein and Membrane glycoproteins. His Bacteria research incorporates elements of Respiratory burst, Cell envelope and Virulence. His study explores the link between Bactericidal/permeability-increasing protein and topics such as Cytotoxic T cell that cross with problems in Degranulation.

He most often published in these fields:

  • Biochemistry (57.78%)
  • Microbiology (35.56%)
  • Escherichia coli (25.00%)

What were the highlights of his more recent work (between 2010-2020)?

  • TLR4 (24.44%)
  • Biochemistry (57.78%)
  • Cell biology (13.89%)

In recent papers he was focusing on the following fields of study:

Jerrold Weiss spends much of his time researching TLR4, Biochemistry, Cell biology, Lipid A and Lipopolysaccharide. His biological study spans a wide range of topics, including Extracellular, Molecular biology and Tumor necrosis factor alpha. His Biochemistry research includes themes of Biophysics and Bacteria.

The Bacteria study combines topics in areas such as Phospholipase A2 and Potency. Within one scientific family, Jerrold Weiss focuses on topics pertaining to Microbiology under Potency, and may sometimes address concerns connected to Escherichia coli. His studies in Lipopolysaccharide integrate themes in fields like Bacterial outer membrane and Vesicle.

Between 2010 and 2020, his most popular works were:

  • The TLR4 antagonist Eritoran protects mice from lethal influenza infection (289 citations)
  • High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses (90 citations)
  • Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2 (77 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Bacteria

His main research concerns TLR4, Lymphocyte antigen 96, Lipid A, Immunology and Cell biology. He has included themes like Molecular biology and Eritoran in his TLR4 study. His work in Molecular biology addresses subjects such as Tumor necrosis factor alpha, which are connected to disciplines such as Virology, CD14, Fusion protein, Toll-like receptor and Proinflammatory cytokine.

His Lymphocyte antigen 96 research is multidisciplinary, incorporating elements of Wild type, Stereochemistry and Ectodomain. His Lipid A study combines topics in areas such as Acetylation and Mutant. His work on Bone marrow, Antigen, T cell and Lipopolysaccharide as part of his general Immunology study is frequently connected to Nucleosome binding, thereby bridging the divide between different branches of science.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.

J Weiss;P Elsbach;I Olsson;H Odeberg.
Journal of Biological Chemistry (1978)

674 Citations

High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.

H Gazzano-Santoro;J B Parent;L Grinna;A Horwitz.
Infection and Immunity (1992)

432 Citations

Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations

Theresa L. Gioannini;Athmane Teghanemt;DeSheng Zhang;Nathan P. Coussens.
Proceedings of the National Academy of Sciences of the United States of America (2004)

426 Citations

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

Kari Ann Shirey;Wendy Lai;Alison J. Scott;Michael Lipsky.
Nature (2013)

423 Citations

Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship.

P Elsbach;J Weiss;R C Franson;S Beckerdite-Quagliata.
Journal of Biological Chemistry (1979)

416 Citations

Neutrophil elastase targets virulence factors of enterobacteria.

Yvette Weinrauch;Doreen Drujan;Steven D. Shapiro;Jerrold Weiss.
Nature (2002)

406 Citations

NEUTROPHILS EXPOSED TO BACTERIAL LIPOPOLYSACCHARIDE UPREGULATE NADPH OXIDASE ASSEMBLY

F R DeLeo;J Renee;S McCormick;M Nakamura.
Journal of Clinical Investigation (1998)

389 Citations

Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.

J Weiss;P Elsbach;C Shu;J Castillo.
Journal of Clinical Investigation (1992)

341 Citations

Role of the bactericidal/permeability-increasing protein in host defence.

Peter Elsbach;Jerrold Weiss.
Current Opinion in Immunology (1998)

314 Citations

Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils.

Jerrold Weiss;Jerrold Weiss;Inge Olsson;Inge Olsson.
Blood (1987)

306 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jerrold Weiss

Makoto Murakami

Makoto Murakami

University of Tokyo

Publications: 49

Ofer Levy

Ofer Levy

Boston Children's Hospital

Publications: 39

Gérard Lambeau

Gérard Lambeau

Centre national de la recherche scientifique, CNRS

Publications: 31

Tomas Ganz

Tomas Ganz

University of California, Los Angeles

Publications: 30

Roman Jerala

Roman Jerala

National Institute of Chemistry

Publications: 30

William M. Nauseef

William M. Nauseef

University of Iowa

Publications: 30

Philippe J. Sansonetti

Philippe J. Sansonetti

Institut Pasteur

Publications: 29

Michael H. Gelb

Michael H. Gelb

University of Washington

Publications: 29

Jonathan C. Kagan

Jonathan C. Kagan

Boston Children's Hospital

Publications: 26

Charles N. Serhan

Charles N. Serhan

Brigham and Women's Hospital

Publications: 25

Margherita Zanetti

Margherita Zanetti

University of Udine

Publications: 24

Frank R. DeLeo

Frank R. DeLeo

National Institute of Allergy and Infectious Diseases

Publications: 24

Robert I. Lehrer

Robert I. Lehrer

University of California, Los Angeles

Publications: 23

Jamel El-Benna

Jamel El-Benna

Université Paris Cité

Publications: 22

Arturo Zychlinsky

Arturo Zychlinsky

Max Planck Society

Publications: 20

Klaus Brandenburg

Klaus Brandenburg

Leibniz Institute for Neurobiology

Publications: 18

Trending Scientists

Antonio F. Skarmeta

Antonio F. Skarmeta

University of Murcia

William H. Sanders

William H. Sanders

Carnegie Mellon University

James R. Carpenter

James R. Carpenter

University College London

Tutut Herawan

Tutut Herawan

University of Malaya

Marko Grobelnik

Marko Grobelnik

Jožef Stefan Institute

James K. Mitchell

James K. Mitchell

Rutgers, The State University of New Jersey

John K. Colbourne

John K. Colbourne

University of Birmingham

Mattias Jonsson

Mattias Jonsson

Swedish University of Agricultural Sciences

Colin Dingwall

Colin Dingwall

King's College London

Steven W. Edwards

Steven W. Edwards

University of Liverpool

Wayne C. Shanks

Wayne C. Shanks

United States Geological Survey

Helen Bronte-Stewart

Helen Bronte-Stewart

Stanford University

Garry D. Honey

Garry D. Honey

Roche (Switzerland)

Nicholas J. Patronas

Nicholas J. Patronas

National Institutes of Health

Dionyssios Katsaros

Dionyssios Katsaros

University of Turin

Catherine Derom

Catherine Derom

KU Leuven

Something went wrong. Please try again later.